EP1206566A2 - Banque de bacteriophages utile dans le typage de bacteries et systeme et procede reposant sur l'utilisation de cette derniere - Google Patents

Banque de bacteriophages utile dans le typage de bacteries et systeme et procede reposant sur l'utilisation de cette derniere

Info

Publication number
EP1206566A2
EP1206566A2 EP00939025A EP00939025A EP1206566A2 EP 1206566 A2 EP1206566 A2 EP 1206566A2 EP 00939025 A EP00939025 A EP 00939025A EP 00939025 A EP00939025 A EP 00939025A EP 1206566 A2 EP1206566 A2 EP 1206566A2
Authority
EP
European Patent Office
Prior art keywords
bacteriophages
bacteria
bacterial
library
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00939025A
Other languages
German (de)
English (en)
Other versions
EP1206566A4 (fr
Inventor
Gabriel Teper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spring Diagnosting Ltd
Original Assignee
Spring Diagnosting Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spring Diagnosting Ltd filed Critical Spring Diagnosting Ltd
Publication of EP1206566A2 publication Critical patent/EP1206566A2/fr
Publication of EP1206566A4 publication Critical patent/EP1206566A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00274—Sequential or parallel reactions; Apparatus and devices for combinatorial chemistry or for making arrays; Chemical library technology
    • B01J2219/00718—Type of compounds synthesised
    • B01J2219/0072—Organic compounds

Definitions

  • the present invention relates to a library of bacteriophages and an array system and method incorporating same which are useful for typing bacteria. More particularly, the present invention relates to a library including wild type and mutant phages, which phages are presented in an array configuration which produces a displayed pattern of infection which is unique to a bacterial type.
  • Non typhoid Salmonellosis is one of the most prevalent among food borne diseases in the United States. In the last two decades, the World wide increase in Salmonellosis cases is thought to be linked, at least in part, to centralized food production and large-scale food distribution practices adopted and practiced by modern food industries.
  • Bacterial systematics is the discipline that deals with identification and grouping of bacteria into groups. It employs three tools: (i) classification - the arrangement of bacteria into groups according to genetic characteristics; (ii) nomenclature - the naming of bacteria, according to internationally accepted standards; and (iii) identification - the comparison of unknown bacteria with already classified bacterial standards on the basis of phenotypic/genetic characteristics.
  • the basic unit for classification in bacteriology is the species.
  • a species in bacteriology consists of a type strain, grouped together with all other strains that are sufficiently similar to that type strain.
  • the type strain is a strain that has been designated as the standard example of that species. All other strains being considered for inclusion in a species must be compared with the type strain of that species.
  • Cultures of type strains can be purchased from various reference collections. Qualitative characteristics of phenotypic properties, such as morphology, structure, cultivation, nutrition, biochemistry, metabolism, pathogenicity, antigenic properties, and ecology are used in traditional and routine classification tests.
  • a relationship between bacterial isolates can also be tested on the genetic level.
  • the great advantage of bacterial genetic classification is that, since it depends on factors which are stable, the resultant classification is not subject to constant change.
  • genetic classification of bacteria in most cases, relies on sequence comparison of ribosomal DNA (encoding ribosomal RNA, rRNA).
  • DNA hybridization and sequencing techniques allow comparison of the entire genome of different bacterial strains. This helps to resolve many taxonomic problems, since it is assumed that bacterial isolates having significantly different DNA base composition do not belong to the same species.
  • DNA hybridization techniques allow comparison of the entire genome of one bacterial isolate with that of other isolates or standards on the basis of nucleotide base sequence.
  • DNA hybridization is most useful at the species level of classification. A species classification based on DNA hybridization can usually be readily defined in phenotypic terms, because the strains in the species tend to be very similar to one another not only in genotype but also in phenotype. However, above (genus and higher) and below (strains) the species level, the genotype/phenotype correlation is often difficult to observe.
  • prokaryotic (bacteria) phenotypic characterization is based on molecular variations.
  • the commonly used techniques for bacterial typing include serological analysis, biochemical analysis, genetic analysis and bacteriophage typing.
  • pathogenic bacteria on the other hand is a process based solely on phenotypic analysis.
  • the assignment of a name to a bacterial isolate is done according to a best fit with a bacterial type standard.
  • bacteriophage typing Several different phenotypic characterization techniques are traditionally utilized to characterize pathogenic bacteria, including bacterial enzymatic activities, surface receptors recognition, surface antigens recognition and bacteriophage infectability (bacteriophage typing).
  • a well calibrated system provides very reliable results. However, reliable results are often difficult to attain under routine conditions since results from control tests which can indicate false reactions are often unreliable.
  • cross reactivity of bacterial surface molecules and poor enzymatic activities in test conditions produce many false results and reduce diagnostic reliability. To overcome such problems, the diagnostic process is performed in several steps using different techniques for each diagnostic test.
  • a semi-accurate identification of the bacterial species can also be provided by the colony morphology when grown on selective solid growth media chosen on the basis of reactivity of the bacteria to selective properties of the growth nutrient.
  • Identification of the bacterial genus and species also requires a standard profile which is generated from activities of several enzymes (e.g., API).
  • the most common method of characterizing pathogenic bacteria involves surface marker typing. This procedure is traditionally performed by an immuno-assay. Many commercial kits are available to this end, which employ monoclonal, polyclonal, or monospecific (e.g., affinity purified) antibodies. In immuno-assays the diagnostic procedure is divided into several consecutive steps. The results can provide a definite antigenic analysis only following a very laborious procedure.
  • the antigenic analysis tests the presence of a small number of surface constituents.
  • monoclonal antibodies it relates to only a single immunogenic determinant (epitope).
  • antibodies do not provide sufficient differential diagnosis for subclassing of bacteria and, therefore, other marker systems must be used.
  • Salmonella enterica serovars S. typhi, S. typhimurium, and S. enteritidis are classified by immune sera but are additionally subdivided by bacteriophage typing sets.
  • Bacteriophages are bacteria infecting viruses which display host specificity. During a course of infection, bacteriophages gain access to the host bacterium via bacterial cell surface constituents (referred to as receptors) through specific recognition and attachment interactions between these receptors and bacteriophage particle surface ligands.
  • receptors bacterial cell surface constituents
  • U.S. Pat. No. 5,888,725 to Sanders describes a method for detection, identification and/or quantification of target organisms of specific bacterial genus, species or serotype, based upon the occurrence of release of cell contents, particularly nucleotides, e.g., ATP, upon lysis of bacteria by bacteriophages (phages) specific for them.
  • bacteriophages can be utilized for bacterial typing currently employed bacteriophage typing methods cannot be used as a sole classification method because of the limited number of phages available for such classification.
  • bacteriophage mediated bacterial typing method devoid of the above mentioned limitations which are inherent to prior art bacteriophage typing methods.
  • a bacteriophage mediated bacterial typing method which is self sustained in that it is sufficiently efficient for genus, species, strain, serovar and pathogenicity typing.
  • a method of producing a plurality of phage mutants useful while implementing bacteriophage mediated bacterial typing method.
  • a bacteriophage library useful for typing bacteria comprising a plurality of bacteriophages being categorized into (a) a first category including bacteriophages being infective to a first type of bacteria; (b) a second category including bacteriophages being infective to a second type of bacteria; and (c) a third category including bacteriophages being infective to both the first type and the second type of bacteria.
  • a method of typing bacteria present in a sample comprising the steps of (a) incubating the sample with an arrayed library of bacteriophages being categorized into (i) a first category including bacteriophages being infective to a first type of bacteria; (ii) a second category including bacteriophages being infective to a second type of bacteria; and (iii) a third category including bacteriophages being infective to both the first type and the second type of bacteria; and (b) identifying bacteriophages being infective to at least one bacteria in the sample; and (c) correlating between an identity of the bacteriophages being infective to the at least one bacteria and an identity of bacteriophages of the library known to be infective to bacterial standards, so as to enable typing of the at least one bacteria present in the sample.
  • the step of incubating the sample with the library of bacteriophages is performed in a presence, or with subsequent addition of, an assay reagent for identifying presence or absence of infection between any specific bacteriophage of the library and bacteria in the sample.
  • the assay reagent is a polynucleotide intercalating agent selected from the group consisting of ethidium bromide and propidium iodide.
  • the step of incubating the sample with the library of bacteriophages is carried out on or in a medium supporting bacterial growth.
  • the medium is selected from the group consisting of a solid medium and a liquid medium.
  • the bacteriophage library is provided as a preparation selected from the group consisting of a plurality of individual bacteriophage suspensions, a plurality of freeze dried individual bacteriophage powders and a solid support carrying a plurality of individual bacteriophages.
  • a system for typing bacteria present in a sample comprising (a) a library of bacteriophages being categorized into (i) a first category including bacteriophages being infective to a first type of bacteria; (ii) a second category including bacteriophages being infective to a second type of bacteria; and (iii) a third category including bacteriophages being infective to both the first type and the second type of bacteria; and (b) a detector being for detecting a presence or absence of infection between at least one bacteria in the sample and individual bacteriophages of the library.
  • system further comprising a processing unit being for comparing the presence or absence of infection as detected by the detector to a presence or absence of infection between bacteriophages of the library and known bacterial standards, so as to enable typing of the at least one bacteria.
  • system further comprising a processing unit being for comparing the presence or absence of infection as detected by the detector to a presence or absence of infection between bacteriophages of the library and known bacterial standards, so as to enable typing of the at least one bacteria.
  • the library is provided as an array such that each of the plurality of bacteriophages occupies a specific location of the array.
  • the bacteriophages of the array are each provided in a liquid medium.
  • the liquid medium is capable of supporting bacterial growth.
  • the bacteriophages of the array are each attached to a solid support.
  • the solid support is selected from the group consisting of a membrane, an agar surface, a microtiter plate, beads and optic fibers.
  • the detector is capable of visually detecting plaques.
  • the detector is capable of detecting a presence of released bacterial constituent associated with bacterial lysis.
  • a method of uncovering mutant bacteriophages useful in typing bacteria comprising the steps of (a) providing a sample of bacteriophages at a first routine titer dilution; (b) concentrating the sample of bacteriophages to a second routine titer dilution, the second routine titer dilution being more concentrated than the first routine titer dilution; (c) infecting a first bacterial sample with the sample of bacteriophages from step (a); (d) infecting a second bacterial sample identical to the first bacterial sample with the sample of bacteriophages resultant from step (b); and (e) only if the second bacterial sample is lysed, whereas the first bacterial sample is not, isolating bacteriophages from the second bacterial sample, thereby uncovering mutant bacteriophages useful in typing bacteria of the bacterial samples.
  • an array of bacteriophages useful for typing bacteria comprising a plurality of distinct bacteriophages each occupying a distinct location of the array, at least a portion of the plurality of distinct bacteriophages being capable of infecting more than one bacterial host type.
  • the plurality of distinct bacteriophages are attached to a solid support.
  • a method of typing bacteria comprising the steps of (a) providing an array of bacteriophages including a plurality of distinct bacteriophages each occupying a distinct location of the array, at least a portion of the plurality of distinct bacteriophages capable of infecting more than one bacterial host type; (b) reacting the array of bacteriophages with a bacterial sample so as to produce a first pattern of bacterial plaques on the array; and (c) comparing the first pattern to patterns of bacterial plaques resultant from reacting the array of bacteriophages with known bacterial samples, so as to enable typing of the bacterial sample.
  • the library is provided as an array, such that each of the plurality of bacteriophages occupies a specific location of the array.
  • the plurality bacteriophages of the array are each provided in a liquid medium.
  • the liquid medium is capable of supporting bacterial growth.
  • the plurality of bacteriophages of the array are each attached to a solid support.
  • the solid support is selected from the group consisting of a membrane, an agar surface, a microtiter plate, beads and optic fibers.
  • the library includes mutants of known bacteriophages the mutants being characterized by bacterial host specificity different than the known bacteriophages.
  • the first type and the second type of bacteria are each bacteria responsible for a food borne disease.
  • the first type and the second type of bacteria are each of a bacterial genus selected from the group consisting of Salmonella,
  • the first and the second bacteria types are different bacterial species of the same genus.
  • the first and the second bacteria types are different bacterial strains of the same species. According to still further features in the described preferred embodiments the first and the second bacteria types are different bacterial serovars of the same strain.
  • each of the first, second and third categories include N bacteriophages, whereas N is an integer selected from the group consisting of integers between and including 2 and 10,000.
  • the library is sufficiently diversified bacteriophage content so as to enable the typing of all known constituents of a bacterial genus.
  • the present invention successfully addresses the shortcomings of the presently known configurations by providing a bacteriophage mediated bacterial typing method which is self sustained in that it is sufficiently efficient for genus, species, strain, serovar and pathogenicity typing.
  • the present invention further successfully addresses the shortcomings of the presently known configurations by providing a method of producing a plurality of phage mutants useful while implementing bacteriophage mediated bacterial typing method.
  • FIG. 1 is a schematic depiction of a system for typing bacteria according to the teachings of the present invention.
  • FIGs. 2a-d are photographs of agar plates including bacteriophage library constituents incubated with Salmonella virchow bacteria, showing sites of lysis as detected by a plaque assay with each site corresponding to a different phage type of the library utilized.
  • Figures a-d represent four different sets of the S. virchow bacteriophage library developed according to the teachings of the present invention.
  • FIGs. 3a-d are photographs of agar plates including bacteriophage library constituents incubated with Salmonella infantis bacteria, showing sites of lysis as detected by propidium iodide fluorescence with each site corresponding to a different phage type of the library utilized.
  • Figures a- d represent four different sets of the S. infantis bacteriophage library developed according to the teachings of the present invention.
  • FIG. 4 is a graph depicting the relationship between fluorescence and the number of bacterial cells infected and lysed while implementing the method of the present invention.
  • FIGs. 5 and 6 are photographs of the prior art API-STAPH typing method showing the various color markers associated with a positive identification of various strains of Staphylococci bacteria. Each strip corresponds to 7 sets of three (6 sets) and two (1 set) marker groups.
  • FIG. 7 is a table showing the bacteriophage markers of six different isolates (serovars) of Staphylococcus aureus (API profile of 6736153). Red numbers represent the phages positive for all serovars. Black numbers represent the phages infective to only part of the serovars. Bold capital letters represent a specific phage set while the numbers represent phage constituents of the set.
  • FIG. 8 is a table showing positive bacteriophages profiles for various S. aureus serovars isolated from infected bovine udders.
  • Bacterial phage markers unique to 6736152 are marked with blue numbers.
  • Bacterial phage markers unique to bacteria 6737150 are marked with green numbers.
  • Red and black phage marker numbers represent phages infective to bacterial strains 6736153 and 6736151.
  • the pink numbers represent phages infective to strains 6736150 and 6736152.
  • FIG. 9 is a table showing the infectivity of a Staphylococci bacteria phage library.
  • the left column represents propagating Staphylococci strains originating from the international phage typing.
  • the right column represents the marker numbers of phages infective to these strains of Staphylococci. DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • the present invention is of an array, system and method incorporating a plurality of bacteriophage types which can be used to type bacteria.
  • the present invention can be used to type a wide range of bacteria, say, all know bacterial constituent of a genus harboring several thousands bacteria species, strains and serovars of varying degree of pathogenicity, by providing a diversified array of bacteriophages including mutant bacteriophages, which array can be used to type the wide range of bacteria by correlating a specific array infection pattern characterizing a tested bacteria with standard patterns of known bacteria.
  • the term "type" when used in context of bacteria is meant to include either a genus, a species and a subspecies e.g., a strain and/or a serovar.
  • bacteria of a certain type can be bacteria of a certain genus, species or subspecies (strain or serovar).
  • type refers to the host specificity of that bacteriophage, i.e., bacteriophages of different types have somewhat different bacterial type specificity.
  • serovar displays unique antigenic determinant(s), some or all of which may or may not be present on other isolates of a strain or on other strains of a species.
  • Bacteria-phage interactions are substantially more complex than bacteria-antisera interactions, oftentimes involving several, say 2-4, distinct sites of recognition and attachment, each being equivalent in size to an epitope. Therefore, phage-typing can theoretically be employed to replace serotyping and other typing methods, provided sufficient phage diversity in terms of bacterial type specificity are available.
  • infectious refers to the process in which a bacteriophage attaches to, and enters into a host bacteria. Infection can follow either a lytic path in which the bacteriophage propagates within the host leading to host cell lysis, or a lysogenic path in which integration of the bacteriophage genome into the host genome occurs with no initial bacteriophage propagation and cell lysis.
  • infection is used herein to refer to a lytic infection.
  • the bacteriophage library includes a plurality of bacteriophages, which are divided into at least three categories.
  • a first category includes bacteriophages which are infective to a first type of bacteria. That is to say, that each of the bacteriophage members of this category infects a single specific type of bacteria. For example, the bacteriophages of this category can infect a certain bacterial species.
  • the bacteriophage library further includes a second category of bacteriophages which includes bacteriophages infective to a second type of bacteria.
  • This category is similar to the first category with the exception that the bacteriophage constituents of this category infect a different bacterial type, for example, a bacterial species different than that infected by the bacteriophages of the first category.
  • the bacteriophage library according to this aspect of the present invention further includes a third category of bacteriophages which includes bacteriophages infective to both the first type and the second type of bacteria. It will be appreciated that the bacteriophages of the third category are distinct from the bacteriophages of the first and second categories.
  • the first type and the second type of bacteria are each bacteria responsible for a food borne disease. Examples of bacterial genera including such bacterial species include, but are not limited to, Salmonella,
  • Staphylococcus Streptococcus, Shigella, Listeria, Campy icbacter, Klebsiella, Yersinia, Pseudomonas and Escherichia.
  • the first and the second bacteria types are different bacteria species of the same genus.
  • the first and the second bacteria types are different bacterial strains of the same species.
  • the first and the second bacteria types are different bacterial serovars of the same strain.
  • the library of this aspect of the present invention enables the typing of bacteria based on the detection of an infection of bacteria present in a sample with the various library phage constituents. For example, a bacterial isolate which is infected by members of the first and third categories of phages is typed as a first type, while a bacterial isolate infected by members of the second and third categories is typed as a second type. Since the bacteriophage members of this library display varied levels of host cell infectivity, a degree of infectivity, as measured by for example, a degree of lysis can also be used as a typing measure. It will be appreciated that this is the most basic configuration of the library according to the present invention.
  • the library of the present invention includes numerous categories of either bacteriophages infective to one type of bacteria, or infective to more than one type of bacteria. It will be appreciated that since single serovar infective bacteriophages exist as well as single species infective bacteriophages, a library of numerous categories can be constructed including categories of bacteriophage members which are infective to numerous bacterial types along with categories of bacteriophage members which are infective to a single bacterial type. Such libraries are exemplified hereinbelow in Examples 3, 4 and 6 of the Examples section. As exemplified therein any number of categories including any number of bacteriophages can be used to effect bacterial typing. It will be appreciated that the number of bacteriophage categories and the number thereof utilized in a given library depends on the desired level of typing and the diversity of the bacterial genus to be typed.
  • the library is provided as an array, such that each of the plurality of bacteriophages occupies a specific location of the array.
  • an array can be provided on a solid support, such as, for example, a membrane, an agar plate or a microtiter plate, in which cases each bacteriophage member of the library is attached or adhered thereto in a specific predetermined position.
  • agar plates such plates preferably include bacterial growth media so as to support bacterial growth.
  • the array When the array is provided on a membrane, such as, for example, a nitrocellulose or a nylon membrane, in which case a bacterial culture is applied onto the membrane and the membrane soaked with nutrient growth media.
  • the bacteriophage members can also be provided on beads, in which case a single bacteriophage member can be adhered to a single bead.
  • the bacteriophage members can each be provided on an end of an optic fiber, in which case the fiber is used to optically communicate ultra violet light radiation from a light source.
  • each bacteriophage member of the library can be provided as a suspension in, for example, a well of a microtiter plate.
  • the suspension includes a bacterial growth media so as to allow bacterial growth therein.
  • the bacteriophages can be provided either as a pure stock, freeze dried, suspension or the like or as bacterial stock infected with the bacteriophage which can be lysed when needed.
  • the library of the present invention can be used to type bacteria as follows.
  • a sample of an unknown bacterial isolate is incubated with the library array. Infection is monitored (and optionally quantified) at each location of the array.
  • a pattern of infections (presence and absence) is then determined and is compared and matched with patterns obtained from incubating the library of the present invention with known bacterial standards which were typed with prior art methods such as, for example, serotyping.
  • any method suitable for identifying infection can be used by the present invention.
  • infection can be detected by the formation of a plaque resultant from bacterial lysis.
  • infection can be detected via the detection of bacterial lysis by-products, such as, for example, intracellular bacterial polypeptides or polynucleotides which are released from the cell following lysis.
  • bacterial lysis by-products such as, for example, intracellular bacterial polypeptides or polynucleotides which are released from the cell following lysis.
  • intercalating agents which uniquely fluoresce following activation upon intercalation into nucleic acids, such as, but not limited to, ethidium bromide, propidium and other membrane impermeable intercalating agents, which are provided either during or following the infection reaction and which are induced to fluoresce using ultraviolet radiation.
  • membrane impermeable intercalating agents can be used by the present invention such that detection of bacterial polynucleotides by the intercalating agent is correlated to bacterial membrane disruption caused by lysis.
  • system 10 As shown in Figure 1 , to enable real time detection and processing of bacterial lysis reactions, and as such bacterial typing, the library of the present invention is incorporated into a system for typing bacteria, which system is referred to hereinbelow as system 10.
  • System 10 includes a library array 12 which can be provided in any of the forms described hereinabove.
  • System 10 can also include mechanisms enabling automatic provision of a bacterial sample to array 12.
  • library array 12 is a microtiter plate
  • system 10 can include a microtiter plate dispenser such that a sample of the isolate to be typed can be provided to each well of the microtiter plate.
  • System 10 further includes an optical scanning device 14 which serves to collect optical information from array 12.
  • optical information can pertain to the appearance and/or size of plaques.
  • Alternatively and preferably such information includes fluorescence collected from array 12, which fluorescence is generated from an intercalating agent which is added to array 12 prior to or following lysis. To generate such fluorescence array 12 is irradiated with ultraviolet light generated from a light source 16.
  • system 10 includes a processing unit 18 communicating with device 14.
  • Unit 18 serves to automatically compare the pattern obtained by device 14 with a plurality of patterns stored therein to obtain a matching pattern such that typing of the isolate can be effected.
  • the library of the present invention is configured such that the bacteriophages diversity thereof is sufficiently high so as to enable typing of, for example, an entire bacterial species or genus, while, at the same time, by utilizing multi-host specific bacteriophage members, the number of library constituents is kept to a convenient minimum, significantly simplifying the preparation and utilization of such a library.
  • a major inherent limitation to prior art bacteriophage typing methods arises from the limited bacteriophages available for typing. As such, prior art typing methods can only be used to type a very limited range of bacteria.
  • a method of uncovering mutant bacteriophages useful in typing bacteria is effected by first providing a sample of bacteriophages at a first routine titer dilution (RTD).
  • RTD routine titer dilution
  • a typical RTD ranges from 1 to 3 units.
  • This sample of bacteriophages is propagated in a first bacterial type which is an infectable host for these bacteriophages.
  • the sample is then concentrated to a second RTD higher than that of the first RTD, say above 5 RTD. This enables concentrating any mutants present within the sample to a concentration which enables initiation of infection.
  • the bacteriophage library includes mutants of known bacteriophages. These mutants are characterized by bacterial host specificities different than that of the known bacteriophages, their progenitors. Bacteriophage libraries which include mutants uncovered according to the teachings of this aspect of the present invention are further detailed in Examples 4 and 6 of the Examples section.
  • Antigenic analysis of surface molecules is currently considered one of the most effective methods to type bacteria. Results obtained from analysis of bacterial surface markers are however difficult to interpret due to several limitations imposed upon such methods.
  • Clonal stability of pathogenic bacteria is an important phenotypic characteristic. This property is oftentimes masked by lateral mobility of pathogenic related molecules such as plasmid DNA. Such molecules when expressed within bacteria may leads to an altered phenotype.
  • Cross reactivity of surface molecules can also limit antigenic analysis of some pathogenic members of closely related bacteria.
  • the problem of antigenic analysis of pathogenic bacteria is even more pronounced when bacterial regulatory pathways are altered by ecological pathways thus contributing to inconsistencies in molecular expression and as a result of which inconsistencies in a phenotype of a particular bacteria.
  • markers For economic reasons, a small number of markers (mostly one per bacterial type) are used for serotyping of most pathogenic bacteria by currently employed commercial kits. Theoretically co-analysis of multiple antigenic determinant can resolve the problem. However, such marker systems are available for a very limited range of bacteria.
  • One example of a multiple antigenic determinant system is the system designed to type Salmonella enter ica which was developed because of the economic importance associated with the detection of this bacteria.
  • the method system and library array of the present invention which are based on the use of bacteriophage libraries in place of antibodies overcome the problems inherent to prior art bacterial typing methods.
  • the information obtained by the use of phage library specific for Salmonella enterica is as accurate as many mono- specific prior art anti-sera assays.
  • the advantage of the method of the present invention is that the typing is performed in a single stage taking 1-2 hours instead of the several days the immune sera based test requires.
  • the data obtained for the diagnosis of Staphylococci using a bacteriophage library constructed according to the teachings of the present invention demonstrates that it is possible to differentiate these bacteria on the level of species (the coagulate positive S. aureus and coagulate negative Staphylococci) or strain.
  • the present invention provides a rapid and accurate method of classification or typing for these bacteria, for which at present no accurate prior art typing methods exist.
  • the multiple marker system generated from the use of the phage library of the present invention reveal an ordered pattern of distribution of the bacterial surface phage markers. Even though the above information is obtained from a limited number of bacterial systems, some general assumptions can be made. The two marker categories of Staphylococcus aureus which originated from bovine mastitis cases suggests that the surface of these bacteria contain a stable molecular fraction and a non stable molecular fraction. These two categories of markers can explain the existence of subspecies which are unique for each different host, and the existence of pathogenicity. The existence of similar marker systems in Salmonella hadar and Salmonella agona suggest that this type of molecular surface organization might also exist in other important pathogenic bacteria.
  • the method of the present invention is more accurate and less prone to false reactions due to unintentional cross reactivity than a method using antisera typing which is dependent in most cases on the identification of only one determinant. Additional objects, advantages, and novel features of the present invention will become apparent to one ordinarily skilled in the art upon examination of the following examples, which are not intended to be limiting. Additionally, each of the various embodiments and aspects of the present invention as delineated hereinabove and as claimed in the claims section below finds experimental support in the following examples.
  • Nutrient broth 8 g/1 Nutrient base (Difco, USA) + 5g/l NaCl + distilled water sterilized at 121 °C for 20 minutes.
  • Nutrient agar Nutrient broth + 15 g/1 Bacto agar (Difco, USA) sterilized at 121°C for 20 minutes. Rich nutrient broth and agar: As above, with the addition of 20 g/1 nutrient base.
  • Agar plates for phage typing are made from rich nutrient agar + 20 ml/1 of 2 % CaCl2-7H2 ⁇ added to the sterilized agar at a temperature of 50 °C.
  • Soft Agar 5 g/1 Nutrient agar (Difco, USA) + distilled water and
  • EXAMPLE 1 Identification of standard bacteria Standardization of Staphylococci bacteria: Two hundred wild type Staphylococci bacteria isolates were collected from mastitis infected milk. Bacteria from contaminated milk samples were grown on blood agar plates. Single hemolytic colonies were identified as Staphylococcus aureus according to a positive coagulase test. Coagulase negative suspected Staphylococci bacteria were isolated according to their colony morphology on blood agar plates. All bacteria were tested by the API standard test for Staphylococci (API-STAPH, bioMerieux, France, http ://www.biomerieux- vitek. com/) .
  • API-STAPH test The API-STAPH test consists of biochemical reactions of a pure tested bacterial culture with 19 substrates.
  • the substrates utilized in this test are: D-glucose, D-Fructose, Maltose, Lactose, D-Trehalose, D-Mannitol, Xylitol, D-Melibiose, Potassium nitrate, ⁇ -naphthyl-acid phosphate, Sodium pyruvate, Raffinose, Xylose, Sucrose, -methyl-D-glucoside, Arginine and Urea.
  • a positive reaction in this test is indicated by a color change of any of the substrates used.
  • the reaction markers are grouped into 7 groups of three markers each. Scores of 0, 1, 2 and 4 are given to the reactions of each of the three markers of the 7 marker groups, a negative reaction rating a "0", while a positive reaction rating " 1", "2" or "4" according to marker values.
  • a final bacterial profile consists of a score for each of the 7 groups which is in fact composed of the individual scores of the 3 marker groups.
  • Typical API profiles of 12 Staphylococcus strains are shown Figures 5 and 6. The whole profile refers to a specific Staphylococcus strain. Typical values for the coagulase positive Staphylococci (Staphylococcus aureus) are 6736130 to 6736153. S. sciuri and S.
  • S. aureus are closely related to S. aureus and they have an API profile of 6736050 and 6736552 respectively.
  • Another Staphylococci bacteria present in mastitic cows is S. chromogenes, which is classified as having an API of
  • Staphylococcus aureus are referred to as coagulase negative
  • Staphylococci The API test is routinely used for the diagnosis of Staphylococci bacteria and is accepted as a standard test. The identification obtained is based on the classification of Kloos and Schleifer (see, for example, Kloos and Schleifer, J. Clin. Microbiol. 1 :82-88, 1975; Radebold, K., Essers L. Evaluation of the API-Staph Micro- System for Routine Identification of Staphlococci (1980) Art. Lab 26, 236-238; Pascoli L., Chiaradia V., Micignat G., Santini G., Identification of Staphylcocci by the API - Staph, (1986) Eur, J. Clin. Microbiol. 5, 6, 669-671).
  • Salmonella isolates Wild type Salmonella bacteria were collected from contaminated food. All suspected Salmonella bacteria were grown on brilliant green agar, a selective media for Salmonella (Difco, USA). One thousand Salmonella isolates belonging to 35 different serovars were identified using standard agglutination serum for Salmonella used according to the protocol of the World Health Organization (WHO) Collaborating Center for Reference Research on Salmonella (1997) at the Institute Pasteur, Paris, France. Table 1 below lists the bacterial serovars and the antigenic formula obtained from the diagnosis of the bacteria in this collection.
  • WHO World Health Organization
  • the 35 types of Salmonella isolates have 10 to 100 repeating copies. They include greater than 90 % of the major non -typhoid contaminating Salmonella types found in Israel in the last 5 years. TABLE 1
  • a phage set includes up to 30 phages active against a portion of the bacterial stock. Bacteriophages
  • phages were isolated from lysogenic bacteria by standard Mitomycin induced release of temperate phages (using Mitomycin C from Sigma
  • a 200 ⁇ l sample of the supernatant was added to 0.5 ml of bacterial culture and plated on a nutrient agar plate. Excess bacterial fluid was aspirated and the plate was allowed to dry in a laminar flow hood. The plate was then incubated for 18 hours at 37 °C. Single phage infections were demonstrated by the formation of small individual plaques. Each single plaque was collected into 2 ml of the starting bacterial culture and incubated at 37 °C for 18 hours. Propagation was performed by transferring 200 ⁇ l of the phage supernatant into 5 ml of soft agar which includes 200 ⁇ l of the bacterial culture in nutrient broth.
  • the soft agar was plated on a rich nutrient agar plate and incubated at 37 °C for 18 hours.
  • a pure phage suspension was isolated from the soft agar and incubated in 5 ml of nutrient broth to release the entrapped phages. Following centrifugation, the supernatant was filtered through a 0.45 ⁇ m Millipore filter, a drop of chloroform was added and the phage suspension was stored at 4 °C. Determination of phage concentration was achieved by infecting confluent bacterial culture agar plates with serial dilutions of the phage suspension. This enabled to determine the highest dilution which still produces confluent lysis.
  • RTD routine titer dilution
  • the tubes were shaken gently and plated on a nutrient agar plate and the plates were incubated at 37 °C for 18 hours. Phages were collected from the soft agar as described hereinabove. The RTD concentration was determined by serial dilutions and calculated according to the highest dilution that still produced a confluent lysis.
  • Typing of bacteria by phages A bacterial lawn was prepared on nutrient agar 90 mm Petri dishes. A 3 ⁇ l drop of a predetermined phage concentration was applied onto the plates in a pattern of 30 to 60 points which generated a grid or array formation. Following incubation at 37 ° C for 18 hours, plaques were formed at points including matching reactive phages. As determined from these experiments, an optimal typing concentrations for Salmonella and Staphylococci typing phages are of RTD values of 1 and 2, respectively.
  • EXAMPLE 3 Mutant phages and phage libraries Isolating phages mutants: Naturally occurring phage mutants are found in very low titers in pure phage suspensions. Since a threshold concentration is needed in order to initiate infection, phage suspensions including suitable infecting mutants must be concentrated above an RTD value of 5-8. Bacteria are typed with a working solution of phages (RTD of 1-2 for Salmonella and RTD of 1-3 for Staphylococci). Typing is effected as described in Examples 1 and 2. Typing is performed for each bacteria with both the concentrated phage suspension (above RTD of 5-8) and an optimal typing concentration (RTD of 1-3).
  • Phage libraries were prepared for Staphylococci and non-typhoid Salmonella enterica. In both cases the library includes approximately 1,000 phage mutants divided into 6 sets, each reactive against a stock bacterial species. The generation of these sets was performed in 3 steps. Initially, approximately 60 phage variants were collected from the natural environment of the bacteria. Following the collection, a very large number of mutant phages active against a collection of approximately 500 wild type bacteria were generated (sets 2-5). Finally, a 6th set which was designed to react with 1,000 to 5,000 bacteria representing bacteria from various geographical sources was generated.
  • the Staphylococci initial set contained 30 phages from standard phage typing sets (Colingdale, London, England) which was acquired from the bacteriological laboratory of Asaph-Harophe hospital in Israel.
  • 30 new phages were isolated from lysogenic bacteria (phages presented in the bacterial genome) by the standard Mitomycin induced phage-releasing method (see Example 1).
  • Bacteria originating from bovine mastitis cases were identified in the Mastitis central laboratory in Saesarea , Israel.
  • the initial phage set for Salmonella contained 12 phages from the international standard phage typing set (Colingdale, London).
  • the bacteriophages include the phage set for Salmonella enter itidis: SE-1, SE-11, SE-17, SE-22, SE-34, SE-37, SE-42, SE-44, and the phage set for Salmonella typhymurium: ST-1, ST- la, ST-2, ST-2a, ST-2c, ST-B, ST-C, ST-H, ST-G, ST-F, IO.
  • These phage sets were acquired from the Central laboratories, of the Ministry of health, Jerusalem, Israel.
  • An additional 48 phages were isolated by Mitomycin induced phage release from lysogenic wild types bacteria.
  • the Salmonella bacteria were received from the central laboratory for food control of the Kimron Veterinary Institute, Beit- Dagan, Israel.
  • Phage concentrations were adjusted to an RTD value of 3.
  • a 0.5 ⁇ l aliquot of each of the various phage strains was spotted onto a nitrocellulose membrane (pore size of 0.2 ⁇ m, Millipore) to form a marked grid pattern similar in size, spacing and pattern to 96 well microtiter plates.
  • a device which contains a 4 x 4 array of pins spaced so as to match a portion of a microtiter plate was fabricated. This device was used to transfer phage stocks from the culture plates onto a sterile filter membrane by applying 16 phage strains onto the membrane at a time.
  • This coordinate pattern of phages matches the pattern of wells in microtiter plates, such that when the nitrocellulose membrane immobilized phages are applied to a microtiter plate which contains bacteria, each phage spot is matched to a well.
  • the membranes were coated with a 1 % alginate gel.
  • the membrane was placed on a Wattman # 1 filer paper soaked with sterile double distilled water (ddw) and sealed with a plastic wrap. Detection of the interaction between bacteria and a positive phage: The interaction between bacteria and positive phages (infection) can be detected in suspension or on solid phase.
  • bacteria When bacteria are lysed by a phage, bacterial nucleic acids are released and are detectable and quantifiable by, for example, interaction with an intercalating agent, propidium iodide in this case, which is not penetrating into intact cells. Bacterial lysis can be visualized by providing propidium iodide in the growth media, such that fluorescence is generated when a lysed sample is illuminated by ultra violet light. Released bacterial nucleic acids are present in detectable quantities after two hours of incubation with a concentrated phage stock.
  • the phage library that was developed for the typing of the Salmonella virchow bacterial collection consists of 5 sets, each set containing 60 different phage types (a total of 300 different phage types). The sets are marked with Roman numerals on the plates ( Figures 2a-d, 3a-d, one set is not shown) and with the letters "A" to "E” in the tabulated data. In each of the five sets, the phage numbers run from 2 to 63.
  • the phage printing device described above uses a standard 96 well ELISA plate as a source for distribution of the different phage types. Reading of results was performed by a scanner (Power II Umax, USA) controlled by a personal computer (PC) and standard scanning software.
  • Reading the positive plaques was performed by a dedicated software program written in Visual C++.
  • Figures 2 and 3 show patterns typical of S. virchow (248) and S. infantis (249), respectively. In these Figures only phage sets 1-4 are shown (set 5 is omitted).
  • a typical database result is shown in Table 2 below.
  • the entire Table (3 parts) represents the results of the typing of a single bacterial species - S. virchow.
  • Various bacterial isolates of the variant S. virchow are marked in the first row.
  • the phage set is represented by the letters A to E.
  • the numbers 2-63 represent phage numbers in each set.
  • the symbols (+) and (-) represent the presence or absence of reactivity for the phage markers used. Cumulative results for isolates of S. virchow (248), S. infantis
  • Threshold analysis shows the distribution of positive markers among various isolates which belong to the same bacterial serovar.
  • a typical list of threshold analysis for S. virchow (248) is shown in Table 4 below. The threshold column which ranges from 60
  • % to 100 % represents the percentage of the isolates having a positive reaction (infected by) with a given phage.
  • the phage set is marked by a letter and a number which represent the position of the phage on the plate.
  • Duplicate analysis uncovers all phages which cross react with a given bacterial set. Table 5 below lists these phages. The reactivity of any given phage marker that shares reactivity with other phages is analyzed so as to avoid including similar phages within the same library collection. Duplicate reactivity' for the Salmonella bacteria was analyzed for a set of 500 isolates from contaminated food in Israel. At 100 % threshold no duplicates were uncovered. As such, it was decided to perform the analysis at a 95 % threshold of identity. Duplicate phage markers were excluded from any of the libraries utilized.
  • List of all positives A list of all the positive phage markers which are reactive to isolates of, for example, serovars 248, 249 and 289 (S. virchow, S. Infantis and S. tennessee, respectively) are shown in Table 3.
  • the best ten The best ten phage markers for the 35 Salmonella enterica serovars are listed in Table 1.
  • the bacterial numbers refer to the serial number published in the 1997 edition of the official publication of WHO collaborating Center for Reference and Research on Salmonella, Pasteur Institute, Paris France.
  • the best ten phage markers, for a given bacteria serovar are selected according to their cross reactivity with the specific serovar but also according to their cross reactivity with other serovars.
  • the best ten phages for the bacteria S. virchow and S. infantis are marked in bold in Table 3.
  • Group analysis Group analysis shows phage markers presented only in all members of a given bacterial group.
  • the bacteria 248, 249 and 289 (S. virchow, S. infantis and S. tenesee respectively) all include the immune serum marker 0:7.
  • the phage marker for this group is A54, as indicated in Table 6 below. TABLE 6 Phage marker exclusive to the 0: 7(C1) antisera typed bacterial serovar group
  • Bacterial saline suspensions were adjusted to 0.1 O. D. at A450 nm.
  • the phage concentration employed ranged from an RTD value of 1 to 6 and depended on the specific phage or phage library used.
  • One part of a bacterial suspension was mixed with one part of a phage suspension in 0.01 M phosphate buffer pH 7.7 including 0.2 % CaCl 2 7-H 2 0.
  • a library of 600 phage markers was prepared for the diagnosis of Staphylococci bacteria isolated from bovine mastitis infected cows.
  • Staphylococci which is composed of 25 type strains for coagulase positive bacteria (Staphylococcus aureus) and 15 type strains for Staphylococci coagulase negative bacteria (S. hycus, S. carnosus, S. chromogenes, S. xylosus) was used as a reference.
  • An API-STAPH test was performed for all bacteria (Biomeriue, France). API results are shown in Figures 5-6.
  • the infective phages of each strain are presented in Figures 7, 8 and 9.
  • Figure 7 depicts the different isolates (serovars) of Staphylococcus aureus (API profile of 6736153) which were analyzed with a library including 600 phage markers (designated by numbers). 100 % threshold analysis of common phage markers shows 57 positive phages which are infective to all bacterial isolates. These phage markers are marked red in Figures 6 and 7. The phages which are infective to only a portion of the bacterial isolates are marked by black numbers.
  • Bacteria 44, 47, 127 and 125 were also isolated from cows with mastitis. Bacteria 44 and 47 both have an API profile of 6736150, while bacteria 127 and 125 have an API profile of 6736152. The common markers for bacteria 127 and 125 were marked in blue while the rest of the markers are marked pink ( Figure 8). Common markers from bacteria 47 and 44 (sharing a common API profile of 6736150) were marked green. Green and blue markers are presented by bacteria having API profiles of 6736150 and 6736152, indicating a possible relationship between bacteria having markers indicated herein by the blue, green and pink colors. The black and red marked marker groups are different and are present in bacteria having API profiles of 6736151 and 6736153.
  • Figure 9 presents non mastitis related S. aureus bacteria which show some cross reactivity with phages infective to bacteria presenting the red-black, blue-green-pink marker groups.
  • PS-42E and PS-81 are bacteria used as propagating strains for phages that are a part of the standard phage typing set for S. aureus (originated from the international center for phage typing in Colingdale, London, England). These bacteria have an API profile of 6736150. The low reactivity of these bacteria with the phage library prepared for the mastitis related S. aureus bacteria suggests a possible different origin.
  • the PS-42E bacteria shows some relation to bacteria presenting the blue-green-pink markers, while the PS- 81 bacteria, having an API profile similar to that of PS-42E, are cross reactive with phages associated with the black markers system.
  • the PS- 96 bacteria an additional propagating strain, has an API profile of 6763130, is poorly marked, and shows no cross reactivity with phages associated with the above markers systems.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

L'invention concerne une banque de bactériophages utile dans le typage de bactéries. La banque de bactériophages comprend plusieurs bactériophages catégorisés a) en une première catégorie comprenant des bactériophages pouvant infecter un premier type de bactéries, b) en une deuxième catégorie comprenant des bactériophages pouvant infecter un second type de bactéries, et c) en une troisième catégorie comprenant des bactériophages pouvant infecter aussi bien le premier type que le second type de bactéries.
EP00939025A 1999-06-25 2000-06-22 Banque de bacteriophages utile dans le typage de bacteries et systeme et procede reposant sur l'utilisation de cette derniere Withdrawn EP1206566A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US14074999P 1999-06-25 1999-06-25
US140749P 1999-06-25
US43664799A 1999-11-09 1999-11-09
US436647 1999-11-09
PCT/IL2000/000366 WO2001000786A2 (fr) 1999-06-25 2000-06-22 Banque de bacteriophages utile dans le typage de bacteries et systeme et procede reposant sur l'utilisation de cette derniere

Publications (2)

Publication Number Publication Date
EP1206566A2 true EP1206566A2 (fr) 2002-05-22
EP1206566A4 EP1206566A4 (fr) 2002-07-17

Family

ID=26838458

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00939025A Withdrawn EP1206566A4 (fr) 1999-06-25 2000-06-22 Banque de bacteriophages utile dans le typage de bacteries et systeme et procede reposant sur l'utilisation de cette derniere

Country Status (3)

Country Link
EP (1) EP1206566A4 (fr)
AU (1) AU5423400A (fr)
WO (1) WO2001000786A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1260353C (zh) 2001-07-18 2006-06-21 波兰科学院免疫和实验治疗研究所 用于治疗细菌感染的多价噬菌体制备方法
US20050118567A1 (en) * 2002-01-23 2005-06-02 Merril Carl R. Method for determining sensitivity to a bacteriophage
KR100468317B1 (ko) * 2002-07-27 2005-01-27 주식회사 웰진 단일가닥 환형 분자를 탐침 ｄｎａ로 이용하는 ｄｎａ 칩
PL215522B1 (pl) 2008-09-29 2013-12-31 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Enterococcus
PL212258B1 (pl) 2010-06-20 2012-09-28 Inst Immunologii I Terapii Doswiadczalnej Pan Nowe szczepy bakteriofagów do leczenia zakazen bakteryjnych, zwlaszcza szczepami bakterii lekoopornych rodzaju Stenotrophomonas
PL217019B1 (pl) 2011-08-25 2014-06-30 Proteon Pharmaceuticals Spółka Akcyjna Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie
WO2019040881A1 (fr) * 2017-08-25 2019-02-28 The United State Of America As Represented By The Secretary Of The Navy Procédés d'identification de bactériophages qui peuvent infecter et tuer des bactéries pathogènes infectieuses adaptées à l'hôte
WO2023077316A1 (fr) * 2021-11-03 2023-05-11 深圳华大生命科学研究院 Procédé pour prédire la relation entre un bactériophage et une infection bactérienne

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009370A2 (fr) * 1999-07-30 2001-02-08 Profos Ag Mise en evidence et identification de souches bacteriennes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5888725A (en) * 1992-09-22 1999-03-30 The Secretary Of State For The Minister Of Agriculture Fisheries And Food In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Method for identifying target bacteria

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009370A2 (fr) * 1999-07-30 2001-02-08 Profos Ag Mise en evidence et identification de souches bacteriennes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0100786A2 *

Also Published As

Publication number Publication date
AU5423400A (en) 2001-01-31
EP1206566A4 (fr) 2002-07-17
WO2001000786A3 (fr) 2001-04-05
WO2001000786A2 (fr) 2001-01-04

Similar Documents

Publication Publication Date Title
Reslova et al. xMAP technology: applications in detection of pathogens
Peng et al. Rapid detection of Shigella species in environmental sewage by an immunocapture PCR with universal primers
Liebana et al. Diversity of strains of Salmonella enterica serotype Enteritidis from English poultry farms assessed by multiple genetic fingerprinting
Loens et al. Optimal sampling sites and methods for detection of pathogens possibly causing community-acquired lower respiratory tract infections
Oda et al. Rapid detection of Escherichia coli O157: H7 by using green fluorescent protein-labeled PP01 bacteriophage
Rahman et al. Identification and characterization of pathogenic Aeromonas veronii biovar sobria associated with epizootic ulcerative syndrome in fish in Bangladesh
Segonds et al. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates
Parveen et al. Discriminant analysis of ribotype profiles of Escherichia coli for differentiating human and nonhuman sources of fecal pollution
Betancor et al. Random amplified polymorphic DNA and phenotyping analysis of Salmonella enterica serovar Enteritidis isolates collected from humans and poultry in Uruguay from 1995 to 2002
Prakash et al. Evaluation of nested PCR in diagnosis of typhoid fever
Perry et al. Evaluation of S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus aureus
Pitt et al. Classification, identification and typing of micro-organisms
EP1556502A2 (fr) Analyses permettant de detecter ou de quantifier des pathogenes et des contaminants bacteriens ou viraux
CN101292043A (zh) 利用细菌噬菌体鉴定微生物的方法和装置
Feng et al. Isogenic strain of Escherichia coli O157: H7 that has lost both Shiga toxin 1 and 2 genes
García et al. Usefulness of PCR and antigen latex agglutination test with samples obtained by transthoracic needle aspiration for diagnosis of pneumococcal pneumonia
Wang et al. Detection of Vibrio cholerae O1 and O139 in environmental water samples by an immunofluorescent-aggregation assay
Bidet et al. Detection and identification by PCR of a highly virulent phylogenetic subgroup among extraintestinal pathogenic Escherichia coli B2 strains
CN101375163B (zh) 用噬菌体检测微观活生物体的装置与方法
EP1206566A2 (fr) Banque de bacteriophages utile dans le typage de bacteries et systeme et procede reposant sur l'utilisation de cette derniere
CN115786543A (zh) 一种鉴定和区分鸡白痢沙门菌和鸡伤寒沙门菌的多重pcr检测试剂盒
CN105886663A (zh) 一种锁核酸增敏的猪伪狂犬病毒野毒株荧光定量pcr的检测试剂盒
McIver et al. Detection of astrovirus gastroenteritis in children
Merlino et al. Chromogenic tube test for presumptive identification or confirmation of isolates as Candida albicans
McKay et al. Comparison of two methods for serotyping Campylobacter spp

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020109

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20020604

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RBV Designated contracting states (corrected)

Designated state(s): DE DK FR GB NL

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040103